Iridian Asset Management’s Top Stock Picks

About six to seven weeks after the end of each fiscal quarter, the SEC requires hedge funds and many other large investors to disclose many of their long positions in publicly traded stocks in 13F filings. Iridian Asset Management, a special situations fund managed by David Cohen and Harold Levy, has turned in their homework a bit early and so we have the opportunity to look at what this investment team had in its portfolio at the end of September. Read on for our quick take on the fund’s five largest positions and compare them to previous filings.

Tyco International Ltd. (NYSE:TYC) crept into the top slot in Iridian’s 13F portfolio, as the fund’s position of 5.3 million shares was up from the 5 million that it had reported owning at the end of the second quarter. Tyco recently completed its breakup into three separate businesses, so it is now mostly a fire protection company. It currently trades at 15 times forward earnings estimates and has a market capitalization of just under $13 billion. Read our article from last summer about the investment opportunities in the Tyco breakup. We think it might be best to wait for a full quarter of results from the stand-alone company before taking a position.

Iridian slightly reduced its stake in Wyndham Worldwide Corporation (NYSE:WYN), from 5.1 million shares to 5.0 million. This follows a quarter in which the fund had sold 21% of its Wyndham holdings. The hotel and vacation rentals company saw its earnings fall 9% in the third quarter versus a year earlier, and trades at a fairly high trailing price-to-earnings multiple of 20, but Wall Street analysts expect better performance in 2013 and so the stock trades at 14 times consensus earnings for next year. We’d like to see better results than what the company has done recently, and think that analysts might be being too optimistic.

The fund also liked Omnicare, Inc. (NYSE:OCR), with another small increase in that position to a total of 7.7 million shares. Omnicare is a $3.9 billion market cap healthcare company which provides pharmacy services to senior communities as well as healthcare and correctional institutions. Its earnings doubled last quarter compared to the third quarter of 2011, and the sell-side expects this progress to continue: while its trailing P/E is above 20 it trades at only 10 times forward earnings estimates and at a five-year PEG ratio of 1. We think that it would be worth taking a closer look at the company.

ESL INVESTMENTS

Eastman Chemical Company (NYSE:EMN) was another stock that Iridian sold out of slightly, closing September with 4.5 million shares in the fund’s 13F portfolio. Eastman’s margins have been down, with its most recent quarter showing significantly higher sales than a year earlier but underperforming on the bottom line. It trades at 16 times trailing earnings, and as such would need to rebound in order to justify the current stock price. Eastman is up 49% over the last year and we think that the stock price should stagnate for some time in order to allow the company’s performance to catch up.

Auto parts store AutoZone, Inc. (NYSE:AZO) was another of the fund’s top picks as Iridian bumped its holdings to just over 640,000 shares from about 600,000 three months earlier. Billionaire Eddie Lampert’s ESL Investments had initiated a position in Autozone during the second quarter of the year, as auto-related companies in general become seen as potential value stocks. Autozone trades at trailing and forward P/E multiples of 16 and 12, respectively, and has been experiencing moderate growth. We think that there are better ways to play the auto theme, including the automakers themselves, but investors who don’t like that idea could possible consider Autozone.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!